Brief: Cinclus Pharma Linaprazan Glurate Gets Reimbursement Listing In China, Set To Launch In 2026
08/12/2025 07:17
Dec 8 (Reuters) - Cinclus Pharma Holding publ AB CINPHA.ST: LINAPRAZAN GLURATE EARNS CHINA’S NATIONAL REIMBURSEMENT LISTING AND IS SET TO LAUNCH IN CHINA IN 2026 Source text: ID:nMFN531Fj7 Further company coverage: CINPHA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))